Bud Ecosystem is excited to announce a strategic partnership with Infosys, a global leader in technology services and consulting. This collaboration aims to accelerate the enterprise adoption of Generative AI across industries by addressing key challenges that organizations face in the process.

With the rising interest in harnessing the potential of GenAI, many enterprises encounter obstacles, including high capital and operational costs, as well as a lack of in-house expertise to optimize and scale GenAI system performance. Additionally, adhering to legal standards and guidelines for responsible AI use and cybersecurity is crucial, further complicating the adoption process. These hurdles often prevent businesses from realizing the full value of their investments in GenAI.

Recognizing these challenges, Bud Ecosystem and Infosys are committed to delivering a GenAI solution that offers optimal performance, is easily scalable and portable, complies with AI guidelines and regulations, and ultimately ensures a strong ROI for organizations. Their collaboration aims to empower enterprises to transition to production-ready GenAI solutions, while adhering to AI guidelines and regulations, including those set by the European Union and the White House’s responsible AI framework.

At the heart of this collaboration is Bud Runtime, a hardware agnostic (Universal Runtime) GenAI serving and inference stack developed by Bud Ecosystem that significantly reduces both capital and operational expenditures for enterprises adopting Generative AI. Benchmarking results have demonstrated that Bud Runtime can achieve up to 130 percent better inference performance in the cloud and 12 times better performance on client devices for GenAI applications and reduce the total cost of ownership by up to 55 times. 

Bud Runtime enables organizations to deploy Generative AI across diverse hardware, including CPUs, HPUs, NPUs, and GPUs. Its cost-effective hardware and model utilization, combined with a hybrid deployment and inference architecture and model merging capabilities, significantly lowers the barriers to GenAI adoption. By reducing both capital expenditures and operating costs, Bud Runtime makes it easier for organizations to integrate and scale GenAI solutions.

Through this partnership, Bud and Infosys will enhance their product offerings and go-to-market strategies, focusing on accelerating AI and GenAI adoption among enterprises. This collaboration will introduce Infosys to Bud’s innovative products and facilitate the sharing of industry best practices through technical advisory services. By training Infosys developers and AI professionals on the Bud platform, the partnership will effectively address key challenges in the AI and GenAI landscape. Together, they will showcase integrated solutions at global industry events and provide extensive training for deployment across various infrastructures, whether cloud-based or on-premises.

“Partnering with Infosys is a significant milestone in our journey to empower organizations with cutting-edge GenAI solutions,” said Jithin V.G, CEO of Bud Ecosystem. “Together, we will enable businesses to unlock the full potential of GenAI while adhering to the highest standards of compliance and ethics.”

Additionally, Infosys will develop industry-specific AI and GenAI assets and pursue a joint go-to-market strategy to promote these solutions globally. This partnership will build the necessary capacity for integrating, deploying, and utilizing the identified product portfolio. Infosys will also provide product development engineering services to expedite Bud’s roadmap and offer enterprise production support for Bud’s customers. To further their commitment to AI and GenAI, Infosys will host Bud at their customer innovation center, allowing both parties to showcase their collaborative efforts to prospective clients.